We are live on ! Find out more
BIOSU

BioPlus Acquisition Corp. Unit
BIOSU

Delisted

BIOSU was delisted on the 6th of October, 2023.

Back to rankings

9 hedge funds and large institutions have $9.14M invested in BioPlus Acquisition Corp. Unit in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $9.41M → $9.14M (-$267K)

18% less funds holding

Funds holding: 11 → 9 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$11.8K

Top Sellers

Rank Fund Capital Flow
1
CSS
Cubist Systematic Strategies
Connecticut
-$286K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$105K
3
TAM
Terrapin Asset Management
Florida
-$53.6K

BIOSU Hedge Fund Activity: Q1 2023 in Review

9 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Unit (BIOSU) for Q1 2023, worth a combined $9.14M — down 2.8% from $9.41M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BIOSU and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Clear Street, opening a new position worth an estimated $11.8K. The largest seller was Cubist Systematic Strategies, exiting entirely with an estimated $286K sold.

  • 9 institutional investors held BioPlus Acquisition Corp. Unit (BIOSU) as of Q1 2023, down from 11 in Q4 2022.
  • Funds reported $9.14M of BioPlus Acquisition Corp. Unit stock for Q1 2023, down 2.8% quarter-over-quarter.
  • 1 fund opened new BioPlus Acquisition Corp. Unit positions in Q1 2023 and 3 closed out, a net change of -2 holders.
  • The largest BioPlus Acquisition Corp. Unit buyer in Q1 2023 was Clear Street, an estimated $11.8K added.
  • The largest BioPlus Acquisition Corp. Unit seller in Q1 2023 was Cubist Systematic Strategies, an estimated $286K sold.

Based on aggregated 13F filings for Q1 2023.